Cost considerations in the management of cancer in the older patient

ONCOLOGY

Volumn 21, Issue 7, 2007, Pages 851-857

  McKoy, June M ^a   Fitzner, Karen A ^a   Edwards, Beatrice J ^a   Alkhatib, Motasem ^a   Tigue, Cara C ^a   Nonzee, Narissa J ^a   Bolden, Carlos R ^a   Bennett, Charles L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PATIENT; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEAD AND NECK CARCINOMA; HEALTH CARE COST; HEALTH INSURANCE; HEMATOLOGIC MALIGNANCY; HOSPITAL COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; PROSTATE CANCER; REIMBURSEMENT; REVIEW; SQUAMOUS CELL CARCINOMA; AGED; CLINICAL TRIAL; COST; ECONOMICS; HEALTH CARE DELIVERY; INSURANCE; MEDICAL FEE; MEDICARE; MIDDLE AGED; NEOPLASM; PATHOLOGY; UNITED STATES;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS; COSTS AND COST ANALYSIS; FEE-FOR-SERVICE PLANS; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; MEDICARE; MIDDLE AGED; NEOPLASMS; UNITED STATES;

EID: 34948896017     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. American Cancer Society: Cancer facts and figures 2006. Available at www.cancer.org/docroot/STT/stt_0_2006.asp. Accessed February 1, 2007.
2. Brown ML, Lipscomb J, Snyder C: The burden of illness of cancer: Economic cost and quality of life. Annu Rev Pub Health 22:91-113, 2001.
3. Brown ML, Riley GF, Schulsser N, et al: Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 40(8 suppl):IV-104-IV-117, 2002.
4. SEER Cancer Statistics Review 1975-2003 : Estimated new cancer cases and deaths for 2006 (Table I-1). Available at seer.cancer.gov/csr/1975_2003/ results_single/sect_01_table.01.pdf. Accessed December 19, 2006.
5. American Cancer Society: Cost of cancer on the rise. ACS News Center. Available at www.cancer.org/docroot/NWS/content/ NWS_1_1x_Cost_of_Cancer_On_the_Rise.asp. Accessed December 16, 2006.
6. Balducci L, Lyman GH: Cancer in the elderly: Epidemiologic and clinical implications. Clin Geriatr Med 13:1-14, 1997.
7. Hayman JA, Langa KM, Kabeto MU, et al: Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19:3219-3225, 2001.
8. US Census Bureau: Available at www.census.gov. Accessed February 12, 2007.
9. Harlan LC, Greene AL, Clegg LX, et al: Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23:9079-9088, 2005.
10. Stuart B, Briesacher BA, Shea DG, et al: Riding the rollercoaster: The ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Aff 24:1022-1031, 2005.
11. Berenson A: A cancer drug shows promise, at a price that many can't pay. New York Times February 15, 2006. Available at www. nytimes.com/2006/02/ 15/business/15drug.html?ei=5090&en=62aabaec5acffa8. Accessed December 7, 2006.
12. SegotaE, Bukowski RM: The promise of targeted therapy: Cancer drugs become more specific. Cleve Clin J Med 71(7):551-60, 2004.
13. Bicknell R: The realisation of targeted antitumour therapy. Br J Cancer 92(suppl 1):S2-S5, 2005.
14. Tigue CC, Fitzner KA, Alkhatib M, et al: The value of innovation: The economics of targeted drugs for cancer. Targeted Oncology 2:113-119, 2007.
15. Lyman GH, Kuderer NM, Djulbegovic B: Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysis. Am J Med 112:406-411, 2002.
16. Repetto L, Biganzoli L, Koehne CH, et al: EORTC Cancer in the Elderly Task Force Guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 39:2264-2272, 2003.
17. De Lima M, Giralt S: Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome. Semin Hematol 43:107-117, 2006.
18. Calhoun EA, Bennett CL: Evaluating the total costs of cancer: The Northwestern University Costs of Cancer Program. Oncology (Williston Park) 17:109-114, 2003.
19. National Cancer Institute: Estimates of national expenditures for medical treatment for the 15 most common cancers (Table L2). Cancer Trends Progress Report - 2005 Udpate. Available at progressreport.cancer.gov/doc_detail.asp? pid=1&did=2005&chid=25&coid=226&mid=. Accessed April 18, 2007.
20. Yabroff KR, Davis WW, Lamont EB, et al: Patient time costs associated with cancer care. J Natl Cancer Inst 99:14-23, 2007.
21. Wilson LS, Tesoro R, Elkin EP, et al: Cumulative cost pattern comparison of prostate cancer treatments. Cancer 109:518-527, 2007.
22. Schrag D: The price tag on progress - chemotherapy for colorectal cancer. N Engl J Med 351:317-319, 2004.
23. Stephens JM, Gramegna P, Laskin B, et al: Chronic lymphocytic leukemia: Economic burden and quality of life (literature review). Am J Ther 12:460-466, 2005.
24. Agency for Healthcare Research and Quality: Care of Women in US Hospitals, 2000. HCUP Fact Book No. 3. AHRQ publication no. 02-0044, October 2002. Available at www.ahrq.gov/data/hcup/factbk3/factbk3.htm. Accessed February 26, 2007.
25. Bennett CL, Schumock GT: Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia: Can they improve clinical decision making? Drugs Aging 20:479-483, 2003.
26. Lang K, Menzin J, Earle CC, et al: The economic cost of squamous cell cancer of the head and neck: Findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg 130:1269-1275, 2004.
27. Ramsey SD, Howlader N, Etzioni RD, et al: Chemotherapy use, outcomes, and costs for older persons with advanced non-small cell lung cancer: Evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22:4971-4978, 2004.
28. Langa KM, Fendrick AM, Chernew ME, et al: Out-of-pocket health-care expenditures among older americans with cancer. Value Health 7:186-194, 2004.
29. Arozullah AM, Calhoun EA, Wolf M, et al: The financial burden of cancer: Estimates from a study of insured women with breast cancer. J Support Oncol 2:271-278, 2004.
30. McKoy JM, Weitner BB, Fitzner KA, et al: Cost and burden of cancer: A comparison of breast, prostate, colorectal, lung and head and neck cancer. Under review.
31. Bennett CL, Weinberg PD, Lieberman JJ: Cancer insurance policies in Japan and the United States. West J Med 168:17-22, 1998.
32. Reeder CE, Gordon D: Managing oncology costs. Am J Manag Care 12(suppl):S3-S19 (incl quiz). Available at www.ajmc.com/viewIssue.cfm?ID=2034. Accessed December 20, 2006.
33. American Cancer Society: Making a Part D plan decision. Available at www.cancer.org/docroot/MIT/content/MIT_3_1_Making_a_Plan_Decision.asp?sitearea= MIT. Accessed December 20, 2006.
34. Unger JM, Coltman CA Jr, Crowley JJ, et al: Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 24:141-144, 2006.
35. Hutchins LF, Unger JM, Crawley CA, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061-2067, 1999.
36. Talarico L, Chen G, Pazdur R: Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration. J Clin Oncol 22:4626-4631, 2004.
37. Bugeja G, Kumar A, Banerjee AK: Exclusion of elderly people from clinical research: A descriptive study of published reports. BMJ 315:1059, 1997.
38. National Cancer Institute: Clinical trials covered under the Medicare anti-cancer drugs national coverage decision. Available at www.cancer.gov/ clinicaltrials/developments/NCD179N. Accessed December 19, 2006.
39. Centers for Medicare and Medicaid Services: Medicare coverage - clinical trials. Provider Bulletin. Available at www.cms.hhs.gov/ ClinicalTrialPolicies/Downloads/provider-bulletin.pdf. Accessed December 15, 2006.
40. Suda KJ, Motl SE, Kuth JC: Inpatient oncology length of stay and hospital costs: Implications for rising inpatient expenditures. J Appl Res 6:126-131, 2006.
41. Chang S, Long SR, Kutikova L, et al: Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 22:3524-3530, 2004.